Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant cisplatin + S-1 followed by alternate-day S-1 after complete resection of stage II-IIIA non-small cell lung cancer
jRCTs071180083Completed
- Start
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of cisplatin and tegafur in non-small cell lung cancer (NSCLC). Started Oct 2013; status: completed.
02
Drugs
cisplatintegafur
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on jRCTs071180083.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs071180083.